AgingResearch.NewsJoin free

Sinovac Research and Development

CompanyChina

Sinovac Research and Development develops one asset, in phase 3 (covid-19 vaccine in COVID-19). Mostly vaccine; based in China.

1
Asset
Furthest stage
Phase 3
2
Trials
0
Signals

Pipeline

1

  • covid-19 vaccine

    Inactivated SARS-CoV-2 induces protective immune responses against COVID-19.

    Phase 3, Vaccine, COVID-19, COVID-19 pneumonia

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials2
  • Similar companies6

Intelligence